Mitochondrial & longevity
NAD+
- 500 mg
- 1,000 mg
Custom strengths on request
Not FDA-approved. On FDA's 503A list (May 14, 2026): Category 1, bulk substance under evaluation. Source, May 14, 2026
At a glance
These dosages are a helpful guide, not a prescription. Every clinician is expected to do their own due diligence before prescribing.
Start
750 mg intravenous infusion over 6 h (healthy men, pilot)
Human study
- Frequency
- single infusion
- Route
- intravenous
- Course
- 6 h
Both human studies were IV only; do not apply to SC or IM use. A 500 mg daily IV series was poorly tolerated.
Get a quote
Custom strengths on request. Prices are quoted per clinic.